Skip to content ↓

Conversations on sociotechnical systems

Seminar will focus on technological platforms for on-demand biopharmaceutical manufacturing

MIT Sociotechnical Systems Research Center invites you to its next spring seminar in the "Conversations on Sociotechnical Systems" series on Wed., March 5, from 4:15-5:30 p.m., in E38-615. Light refreshments will be served.

The delivery of biologic drugs to patients can be challenging, if not impossible, in many regions of the world. Patients who could benefit from treatments may live in remote regions, under-resourced areas, or face challenging circumstances, such as natural disasters that limit access to life-saving drugs.

This seminar will focus on a new approach for producing biologic drugs on site and on demand known as integrated and scalable cyto-technology (InSCyT). As a supplement to traditional processes, InSCyT can accelerate drug development and improve global access to customized drugs.

Paul Barone, associate director of the Biomanufacturing Research Program (BioMAN) and Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) within MIT's Center for Biomedical Innovation, will deliver a talk, "Integrated and Scalable Cyto-Technology (InSCyT) Platform for Biopharmaceutical Manufacturing on Demand."


 

Related Links

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story